Cargando…

Identification of neurological disease targets of natural products by computational screening

Detalles Bibliográficos
Autor principal:	Konc, Janez
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788253/ https://www.ncbi.nlm.nih.gov/pubmed/31397338 http://dx.doi.org/10.4103/1673-5374.262576

Ejemplares similares

Recent advances in RNA-targeting therapy for neurological diseases
por: Kumar, Satheesh, et al.
Publicado: (2023)

Computational Genomics of Specialized Metabolism: from Natural Product Discovery to Microbiome Ecology
por: Medema, Marnix H.
Publicado: (2018)

Multi-targeted anti-inflammatory drugs for the treatment of neurological disorders
por: Lui, Austin, et al.
Publicado: (2022)

Transcranial electrical stimulation in neurological disease
por: Brown, Gregory L., et al.
Publicado: (2022)

Inferring the nature of linguistic computations in the brain
por: Ten Oever, Sanne, et al.
Publicado: (2022)

CaNDis: a web server for investigation of causal relationships between diseases, drugs and drug targets
por: Škrlj, Blaž, et al.
Publicado: (2020)

Editorial: Natural products in the treatment of neurological diseases: identification of novel active compounds and therapeutic targets
por: Zhao, Jia, et al.
Publicado: (2023)

Convergence of human and veterinary medicine: leveraging canine naturally occurring neurological disorders to develop regenerative treatments
por: Clark, Kaitlin C., et al.
Publicado: (2022)

ProBiS H2O MD Approach for Identification of Conserved Water Sites in Protein Structures for Drug Design‡
por: Jukič, Marko, et al.
Publicado: (2020)

Looking beyond the hippocampus: old and new neurological targets for understanding memory disorders
por: Aggleton, John P.
Publicado: (2014)

Programmable macromolecule-based RNA-targeting therapies to treat human neurological disorders
por: Morelli, Kathryn H., et al.
Publicado: (2023)

Pharmacological inhibition of cation-chloride cotransporters for neurological diseases
por: Nepomuceno, Rachel, et al.
Publicado: (2015)

Ligand-based virtual screening interface between PyMOL and LiSiCA
por: Dilip, Athira, et al.
Publicado: (2016)

Algorithms in nature: the convergence of systems biology and computational thinking
por: Navlakha, Saket, et al.
Publicado: (2011)

Neurological Dysfunction in Long COVID Should Not Be Labelled as Functional Neurological Disorder
por: Van der Feltz-Cornelis, Christina M., et al.
Publicado: (2023)

Exosomes in neurological disease, neuroprotection, repair and therapeutics: problems and perspectives
por: Kalani, Anuradha, et al.
Publicado: (2015)

ProBiS: a web server for detection of structurally similar protein binding sites
por: Konc, Janez, et al.
Publicado: (2010)

ProBiS algorithm for detection of structurally similar protein binding sites by local structural alignment
por: Konc, Janez, et al.
Publicado: (2010)

ProBiS-2012: web server and web services for detection of structurally similar binding sites in proteins
por: Konc, Janez, et al.
Publicado: (2012)

ProBiS-ligands: a web server for prediction of ligands by examination of protein binding sites
por: Konc, Janez, et al.
Publicado: (2014)

Protein binding sites for drug design
por: Konc, Janez, et al.
Publicado: (2022)

Pesticides and Neurologic Symptoms
por: Burns, Carol, et al.
Publicado: (2005)

Evolving paradigms for natural-product drug discovery
por: Cordell, Geoffrey A
Publicado: (2022)

Natural products are the treasure pool for antimalarial agents
por: Zhou, Bin, et al.
Publicado: (2022)

Computational Identification of Repeat-Containing Proteins and Systems
por: Altae-Tran, Han, et al.
Publicado: (2020)

Disease-directed engineering for physiology-driven treatment interventions in neurological disorders
por: Wood, Thomas, et al.
Publicado: (2019)

Multiple facets of poly(ADP-ribose) polymerase-1 in neurological diseases
por: Sriram, Chandra Shaker, et al.
Publicado: (2015)

Advancing mesenchymal stem/stromal cells-based therapies for neurologic disease
por: Phinney, Donald G.
Publicado: (2017)

Repurposing cancer drugs to treat neurological diseases – Src inhibitors as examples
por: Liu, Da Zhi
Publicado: (2017)

Natural compounds based chemotherapeutic against Chagas disease and leishmaniasis: mitochondrion as a strategic target
por: Lazarin-Bidóia, Danielle, et al.
Publicado: (2022)

AMPK: A Target for Drugs and Natural Products With Effects on Both Diabetes and Cancer
por: Hardie, D. Grahame
Publicado: (2013)

ProBiS-Database: Precalculated Binding Site Similarities and Local Pairwise Alignments of PDB Structures
por: Konc, Janez, et al.
Publicado: (2012)

Structure-Based Function Prediction of Uncharacterized Protein Using Binding Sites Comparison
por: Konc, Janez, et al.
Publicado: (2013)

Implications of Withaferin A in neurological disorders
por: Ram, Natasha, et al.
Publicado: (2020)

Repurposing niclosamide for the treatment of neurological disorders
por: Apolloni, Savina, et al.
Publicado: (2023)

Neurological and Behavioral Consequences of Childhood Lead Exposure
por: Bellinger, David C
Publicado: (2008)

Lifting the mask on neurological manifestations of COVID-19
por: Pezzini, Alessandro, et al.
Publicado: (2020)

Neurological, neuropsychiatric and neurodevelopmental complications of COVID-19
por: Pantelis, Christos, et al.
Publicado: (2020)

Modeling enzyme-ligand binding in drug discovery
por: Konc, Janez, et al.
Publicado: (2015)

Inverse Molecular Docking as a Novel Approach to Study Anticarcinogenic and Anti-Neuroinflammatory Effects of Curcumin
por: Furlan, Veronika, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vhb4o996u7kpmkak3uj62dfbt4